Shalom Auerbach - 07 May 2025 Form 4 Insider Report for OS Therapies Inc (OSTX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
09 May 2025, 21:30:13 UTC
Prior SEC filing
11 Apr 2025
Next SEC filing
09 May 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Shalom Auerbach

Key filing fact

Shalom Auerbach filed Form 4 for OS Therapies Inc (OSTX) on 09 May 2025.

Key facts

  • This page summarizes Shalom Auerbach's Form 4 filing for OS Therapies Inc (OSTX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 09 May 2025, 21:30.

Change

  • Previous filing in this sequence was filed on 11 Apr 2025.
  • Current net transaction value: -$163,918.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (2)

CIK 0002048828 Primary reporting owner

Auerbach Shalom

Relationship
10%+ Owner
Address
15 ATLANTIC AVENUE, SUITE M2, LYNBROOK
Signature
/s/ Shalom Auerbach
Signature date
09 May 2025
CIK 0002048829

Einodmil LLC

Relationship
10%+ Owner
Address
396 OAKLAND AVENUE, CEDARHURST
Signature
/s/ Shalom Auerbach, Principal of Einodmil LLC
Signature date
09 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OSTX transaction

Common Stock, par value $0.001 per share

Sale

Transaction value
$163,918
Shares
-82,000
Change %
-3%
Price
$2.00
Shares after
2,664,199
Date
07 May 2025
Ownership
See Footnote
Footnotes
F1, F2
OSTX holding

Common Stock, par value $0.001 per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
23,371
Date
07 May 2025
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares of Comm Stock were sold in multiple transactions at prices ranging from $1.69 to $2.22 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .